发明授权
- 专利标题: Polypeptide of protein P140 and DNAS encoding it
- 专利标题(中): 蛋白质P140的多肽和编码它的DNAS
-
申请号: US571785申请日: 1995-12-13
-
公开(公告)号: US5804411A公开(公告)日: 1998-09-08
- 发明人: Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
- 申请人: Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
- 申请人地址: JPX Osaka
- 专利权人: Ono Pharmaceutical Co., Ltd.
- 当前专利权人: Ono Pharmaceutical Co., Ltd.
- 当前专利权人地址: JPX Osaka
- 优先权: JPX5-315806 19931124
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; C07K14/47 ; C12N1/21 ; C12N15/12 ; C12P21/08 ; C12P21/02 ; C07H21/04 ; C12N15/63
摘要:
The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector derived the said DNA; host cells transformed the said vector; antibody of the said polypeptide; pharmaceutical composition containing the said peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment of diabetes, agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylate of protein p140, as active ingredient and the screening methods of the said prevention and/or treatment agent. Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only to improve the diabetes-derived hypoglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
公开/授权文献
- US5054579A Ladder having an anchoring system 公开/授权日:1991-10-08
信息查询
IPC分类: